There is growing evidence that patients with positive aPL and/or APS requiring renal transplantation have increased risk of early graft loss due to post-transplant thrombosis of graft vessels or thrombotic microangiopathy (17, 18). This evidence concerns the gene FASLG and autoimmune polyendocrinopathy.